| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/08/2008 | US20080108788 Cell surface receptor for use as tool in identifying modulators of vascular pressure |
| 05/08/2008 | US20080108731 decorative artwork and faux effects that can be applied over concrete; acrylic emulsion, a hard resins and also translucent, uniformly spherical, non-resin, absorbent acrylic or polypropylene beads |
| 05/08/2008 | US20080108564 Peptide covalently bound to Polyethylene glycol; agonists of the erythropoietin receptor (EPO-R), having amino acid sequence; defective red blood cell production |
| 05/08/2008 | US20080108558 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/08/2008 | US20080108552 Beta 1-integrin inhibitory peptide modified by biotin, cystein, or carboxyfluorescein (FAM) |
| 05/08/2008 | US20080108132 Kit for Immobilizing Organic Substance, Organic Substance-Immobilized Structure, and Manufacturing Methods Therefor |
| 05/08/2008 | US20080108123 Fe2O3 complexed biopolymer matrix for use in separation, isolation and delivery of cells, bacteria, drug elements; drug screening |
| 05/08/2008 | US20080108066 Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein |
| 05/08/2008 | US20080107668 Oligopeptides comprising epitopic sequences for use in induction of killer lymphocyte response in treatment of cell proliferative disorders |
| 05/08/2008 | US20080107667 Fusion peptide for use in targeting cells for lympocytic destruction; immunotherapy |
| 05/08/2008 | US20080107625 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107624 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107623 Inhibitors of Hepatitis C Virus |
| 05/08/2008 | US20080107614 Peptide-based conditioners |
| 05/08/2008 | US20080107598 Conjugating a chelator, ethylenedicysteine to a targeting ligand, glucosamine, deoxyglucose, metronidazole, annexin V, guanine or LHRH; and a metal ion of 99mTc, 68Ga, 188Re or 187Re |
| 05/08/2008 | US20080107597 Isolation of antibodies that cross-react and neutralize rankl originating from multiple species |
| 05/08/2008 | CA2667141A1 Novel polypeptides and uses thereof |
| 05/08/2008 | CA2656112A1 Bioresponsive polymers |
| 05/07/2008 | EP1918297A1 Neuronal differentiation-inducing peptide and use thereof |
| 05/07/2008 | EP1918296A2 New antitumoral compounds |
| 05/07/2008 | EP1917970A2 Hla binding peptides and their uses |
| 05/07/2008 | EP1917274A2 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 05/07/2008 | EP1917273A2 Apoe mimetic agents |
| 05/07/2008 | EP1828228B1 Method for the deacylation of lipopeptides |
| 05/07/2008 | EP1654280B1 Preparation of somatostatin peptides |
| 05/07/2008 | EP1649036B1 Method for producing cyclic molecules |
| 05/07/2008 | EP1590366B1 Peptidic sulfonamides |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1372688B1 Somatostatin antagonists |
| 05/07/2008 | EP0986636B1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 05/06/2008 | US7368628 Vectors to express desired amino acid sequence in cells; regeneration; endosperm tissues; rice, corn, wheat, barley |
| 05/06/2008 | US7368529 Protein isolated from plants (Moringa) or recombinant DNA; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 05/06/2008 | US7368528 Salt with physiologically tolerated acid; resistant to enzymatic degradation; oral administration |
| 05/06/2008 | US7368474 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide |
| 05/06/2008 | US7368433 Acetyl-Z-Q-arg-trp-NH2 in which z is derived from amino-2-naphthalenecarboxylic acid and Q is derived from p-iodo-(D)phenylalanine; melanocortin-4 receptor agonist activity; treating obesity, hypertension, type II diabetes, or control of appetite |
| 05/06/2008 | US7368432 Polypeptide analgesics from snail venom; analogous to the naturally available peptides, and which preferably include two disulfide bonds |
| 05/06/2008 | US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
| 05/06/2008 | US7368429 Mimetic polypeptide for treatment and prevention of nervous system disorders; human myelin basic protein (h-MBP) |
| 05/06/2008 | US7368424 peptide antibiotics comprising lysobactin derivatives used for treatment and/or prophylaxis of bacterial infectious diseases; cyclic peptides |
| 05/06/2008 | US7368422 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 05/06/2008 | US7368421 Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
| 05/06/2008 | US7368236 Methods of producing nucleic acid ligands |
| 05/06/2008 | US7368127 Contacting at least one surface of a biomedical device formed from a reactive mixture comprising at least one latent reactive component with a coating effective amount of at least one peptide containing coating |
| 05/06/2008 | US7368119 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 05/06/2008 | CA2283868C Photosensitizer conjugates for pathogen targeting |
| 05/02/2008 | WO2008049974A2 Peptide vaccine for influenza virus |
| 05/02/2008 | WO2008049643A2 Gd2 peptide mimotopes for anticancer vaccination |
| 05/02/2008 | WO2008010098A3 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 05/02/2008 | WO2007101158A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 05/02/2008 | CA2703646A1 Peptide vaccine for influenza virus |
| 05/01/2008 | US20080103292 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/01/2008 | US20080103097 Glucagon-like peptides having one lipophilic substituent which is attached to the C-terminal amino acid; treatment of non-insulin dependent diabetes mellitus |
| 05/01/2008 | US20080102110 simple steps and high yield; low cost and can be used in production on large scale; spacer is a hydrophilic polymer, and the lipid is phosphatidylethanoaminecarbonyl |
| 04/30/2008 | EP1916257A1 GD2 peptide mimotopes for anticancer vaccination |
| 04/30/2008 | EP1915621A2 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 04/30/2008 | EP1915168A2 Ligands of melanocortin receptors |
| 04/30/2008 | EP1664093B1 Antitumoral compounds based on Kahalalide F |
| 04/30/2008 | EP1549670B1 Template-fixed peptidomimetics with antimicrobial activity |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1294747B1 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 04/30/2008 | EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 04/30/2008 | EP1173471B1 Pseudomycin analogs |
| 04/30/2008 | EP1165613B1 Melanocortin receptor ligands |
| 04/30/2008 | CN101168561A Method for separating and purifying microcystin |
| 04/30/2008 | CN101168560A N-substituted peptide amide, pharmaceutical composition and use thereof |
| 04/29/2008 | US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/29/2008 | US7365156 PRO1316 polypeptides |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365154 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/29/2008 | US7365153 Biologically active peptide and agent containing the same |
| 04/29/2008 | US7365054 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
| 04/29/2008 | CA2266416C Insulin c-peptides |
| 04/24/2008 | WO2008048942A2 Receptor(sstr2)-selective somatostatin antagonists |
| 04/24/2008 | WO2008048627A1 Purification processes of echinocandin-type compounds |
| 04/24/2008 | WO2008047473A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | WO2008047370A2 Compositions and methods for inducing angiogenesis |
| 04/24/2008 | WO2008046228A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | WO2006079099A3 Method of conjugating aminothiol containing molecules to a polymer |
| 04/24/2008 | US20080097079 Using intramolecular cystine formation as tool in generating cyclic peptides; vapreotide; somatostatin homologue |
| 04/24/2008 | US20080097078 Antibacterial activity against vancomycin-resistant bacteria |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096816 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096815 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096814 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096809 Diastereomeric Peptides Useful as Inhibitors of Membrane Protein Assembly |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080096246 Zein-based peptide tags for the expression and purification of bioactive peptides |
| 04/24/2008 | US20080095872 using modified Clostridial toxin having an orphanin targeting moiety, a domain for translocating a light chain across an endosome membrane; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/24/2008 | US20080095832 Prosaposin as a neurotrophic factor |
| 04/24/2008 | US20080095821 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 04/24/2008 | US20080095819 Antiproliferative agents; connexins; reducing density of astrocytes; increasing density of neurons; hair growth; cosmetic surgery |
| 04/24/2008 | US20080095715 Cyclic nonapeptides coupled to a cyanine dye as an imaging contrast agent; monitoring angiogenesis inhibition |
| 04/24/2008 | US20080095701 Diagnostic Compounds |
| 04/24/2008 | CA2667030A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | CA2666841A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | CA2666642A1 Receptor(sstr2)-selective somatostatin antagonists |
| 04/24/2008 | CA2662923A1 Purification processes of echinocandin-type compounds |
| 04/23/2008 | EP1913018A1 Biopeptides with anti-hypertensive activity from bovine beta-casein |
| 04/23/2008 | EP1913017A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |